{"DataElement":{"publicId":"2626970","version":"2","preferredName":"Fluorescence in situ Hybridization Cytogenetic Analysis Cell Assessment Lab Percentage ULN Value","preferredDefinition":"The numeric laboratory value representing the upper level of the normal range of values of the fluorescence in situ hybridization cytogenetic analysis cell assessment.","longName":"2626368v1.0:2626968v2.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2626368","version":"1","preferredName":"Fluorescence in situ Hybridization Cytogenetic Analysis Cell Assessment","preferredDefinition":"information related to assessment of the cells in a physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin (FISH) used for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities for the arrangement of chromosomes in the equatorial plane of the central spindle to form the monaster.","longName":"FISH_CYTOANA_C_ASS","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2626363","version":"1","preferredName":"Fluorescence in situ Hybridization Cytogenetic Analysis","preferredDefinition":"A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.:Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","longName":"C17563:C18280","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cytogenetic Analysis","conceptCode":"C18280","definition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E011DAE-5D93-0FBB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-04-13","modifiedBy":"ONEDATA","dateModified":"2007-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2626366","version":"1","preferredName":"Cell Assessed","preferredDefinition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid. Cells are highly variable and specialized in both structure and function, though all must at some stage replicate proteins and nucleic acids, utilize energy, and reproduce themselves.:Having determined the value, significance, or extent of.","longName":"C12508:C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cell","conceptCode":"C12508","definition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E012833-64C6-10C2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-04-13","modifiedBy":"ONEDATA","dateModified":"2007-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E012833-64D7-10C2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-04-13","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2626968","version":"2","preferredName":"Lab Percentage Upper Limit of Normal Value","preferredDefinition":"The information contained in a data field of a fraction or ratio with 100 understood as the denominator fo the top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.","longName":"2626968v2.0","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"%","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2626967","version":"1","preferredName":"Percentage Upper Limit of Normal Value","preferredDefinition":"Percentage; a fraction or ratio with 100 understood as the denominator.:The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.:The information contained in a data field.","longName":"C25613:C25706:C49100","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Upper Limit of Normal","conceptCode":"C25706","definition":"The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Data Value","conceptCode":"C49100","definition":"The information contained in a data field. It may represent a numeric quantity, a textual characterization, a date or time measurement, or some other state, depending on the nature of the attribute.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E04617F-3718-6804-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-04-13","modifiedBy":"ONEDATA","dateModified":"2007-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6051B84C-67D7-07FF-E053-F662850AC48D","latestVersionIndicator":"Yes","beginDate":"2017-12-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-12-14","modifiedBy":"KUMMEROA","dateModified":"2017-12-14","changeDescription":"Versioned to changed the data type from character to number. AK 12/14/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2670694","version":"1","longName":"Disease Relapse","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2812922","version":"1","longName":"Acute Leukemia Relapse","context":"NHLBI"},{"publicId":"2812924","version":"1","longName":"Chronic Myelogenous Leukemia Relapse","context":"NHLBI"},{"publicId":"2812926","version":"1","longName":"Lymphoma Relapse","context":"NHLBI"},{"publicId":"2812925","version":"1","longName":"Fanconi Anemia Relapse","context":"NHLBI"},{"publicId":"2812927","version":"1","longName":"Myelodysplastic Syndrome (MDS) Relapse","context":"NHLBI"},{"publicId":"2812928","version":"1","longName":"Solid Tumor Relapse","context":"NHLBI"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Percent positive ULN","type":"Preferred Question Text","description":"Percent positive ULN","url":null,"context":"NHLBI"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6051BDCA-F28E-109B-E053-F662850A96A8","latestVersionIndicator":"Yes","beginDate":"2007-04-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-12-14","modifiedBy":"KUMMEROA","dateModified":"2021-07-28","changeDescription":". 2021-7-28 ak Released per Janet review. Versioned due to VD data type change.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}